Biogen (BIIB) Other Non Operating Income (2009 - 2015)

Biogen (BIIB) recorded quarterly Other Non Operating Income of -$15.0 million in Q1 2015, down 70.88% quarter-over-quarter from -$8.8 million in Q4 2014, and down 167.56% on a YoY basis from $22.2 million in Q1 2014.

Biogen (BIIB) Other Non Operating Income (2009 - 2015) Analysis & Trends

Biogen's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$15.0 million for Q1 2015.

  • In Q1 2015, Other Non Operating Income fell 167.56% year-over-year to -$15.0 million; the TTM figure through Mar 2015 stood at -$35.2 million (down 35.1% YoY), while the FY2016 annual figure was -$217.4 million, down 75.75% from the prior year.
  • Other Non Operating Income was -$15.0 million for Q1 2015 at Biogen, down from -$8.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $15.1 million in Q1 2012 to a low of -$16.3 million in Q3 2014.
  • Historically, Other Non Operating Income has averaged -$5.9 million across 5 years, with a median of -$5.6 million in 2014.
  • The sharpest annual moves came in 2013 and 2014: Other Non Operating Income plunged 453.49% in 2013, then soared 146.61% in 2014.
  • A 5-year view of Other Non Operating Income shows it stood at -$4.0 million in 2011, then sank by 259.68% to -$14.3 million in 2012, then jumped by 62.39% to -$5.4 million in 2013, then sank by 63.16% to -$8.8 million in 2014, then tumbled by 70.88% to -$15.0 million in 2015.
  • The last three Other Non Operating Income figures came in at -$15.0 million (Q1 2015), -$8.8 million (Q4 2014), and -$16.3 million (Q3 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Biogen 28.75 Bn 24.47 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2015 -14.99 Mn
Dec 31, 2014 -8.77 Mn
Sep 30, 2014 -16.29 Mn
Jun 30, 2014 4.86 Mn
Mar 31, 2014 -5.60 Mn
Dec 31, 2013 -5.38 Mn
Sep 30, 2013 -4.64 Mn
Jun 30, 2013 -10.43 Mn
Mar 31, 2013 -14.46 Mn
Dec 31, 2012 -14.29 Mn
Sep 30, 2012 -4.55 Mn
Jun 30, 2012 2.95 Mn
Mar 31, 2012 15.14 Mn
Dec 31, 2011 -3.97 Mn
Sep 30, 2011 -7.73 Mn
Dec 31, 2010 -4.70 Mn
Sep 30, 2010 -6.90 Mn
Jun 30, 2010 1.00 Mn
Mar 31, 2010 -8.40 Mn
Dec 31, 2009 6.40 Mn